3i Group PLC — Director's Dealing 2026

Mar 30, 2026

National Storage Mechanism | Additional information

RNS Number : 5288Y

3i Group PLC

30 March 2026

Director/PDMR Shareholding

UK Market Abuse Regulation Article 19

On 27 March 2026, 3i Group plc (the "Company") (LEI: 35GDVHRBMFE7NWATNM84) was notified that on 26 March 2026 Simon Borrows, a Director and person discharging managerial responsibilities and certain Persons Closely Associated ("PCA") with him, purchased an aggregate of 350,147 ordinary shares of 73 19/22p each (ISIN: GB00B1YW4409) in the Company ("Shares") at a price of £25.55 per Share.

The PCAs comprise a number of family trusts, each of which is a PCA with Simon Borrows for the purposes of the UK Market Abuse Regulation.

Simon Borrows is Trustee of these trusts and for the purposes of the UK Market Abuse Regulation is deemed to exercise control over their investment decisions.

The transactions took place as follows:  

Director/PCA	Number of Shares purchased
Simon Borrows	39,123
The Borrows 2015 Number 1 Discretionary Settlement	19,561
The Borrows 2015 Number 2 Discretionary Settlement	19,561
The Borrows 2015 Number 3 Discretionary Settlement	19,561
The Borrows 2016 Number 1 Discretionary Settlement	19,561
The Borrows 2016 Number 2 Discretionary Settlement	19,561
The Borrows 2016 Number 3 Discretionary Settlement	19,561
Borrows 2018 No 1 Settlement	29,342
Borrows 2018 No 2 Settlement	29,342
Borrows 2018 No 3 Settlement	29,342
The Borrows 2021 No.1 Discretionary Settlement	15,649
The Borrows 2021 No.2 Discretionary Settlement	15,649
The Borrows 2021 No.3 Discretionary Settlement	15,649
The Borrows Grandchildrens Settlement	58,685

The place of the transactions was the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPUUWWUPQGRM